4//SEC Filing
Regulus Therapeutics Inc. 4
Accession 0001209191-17-013896
CIK 0001505512operating
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 5:21 PM ET
Size
5.3 KB
Accession
0001209191-17-013896
Insider Transaction Report
Form 4
GRINT PAUL C
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2017-02-15+410,000→ 410,000 totalExercise: $1.20Exp: 2027-02-14→ Common Stock (410,000 underlying)
Footnotes (1)
- [F1]25% of the shares vest on January 1, 2018 and the remainder of the shares vest in equal installments on a monthly basis thereafter, such that the option is fully vested on January 1, 2021.
Documents
Issuer
Regulus Therapeutics Inc.
CIK 0001505512
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001505512
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 5:21 PM ET
- Size
- 5.3 KB